Zentalis Pharmaceuticals (United States)
Zentalis Pharmaceuticals | Advancing WEE1-Targeted Oncology
Zentalis Pharmaceuticals is a clinical-stage company advancing azenosertib, a first-in-class WEE1 inhibitor, for ovarian cancer and other tumor types.
Company details
- Address
- United States
- Website
- zentalis.com
Reviews
No reviews yet.
All reviews of Zentalis Pharmaceuticals (United States) · Write a review
Domain and WHOIS record
- Domain
- zentalis.com
- Registrar
- GoDaddy.com, LLC
- Registered
- 5 Nov 2019
- Expires
- 5 Nov 2029
- Record updated
- 6 Nov 2024
- Name servers
- ns13.domaincontrol.com, ns14.domaincontrol.com
- DNSSEC
- Not signed